| 000 | 01563 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514015815.0 | ||
| 264 | 0 | _c20011218 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0014-5793 | ||
| 024 | 7 |
_a10.1016/s0014-5793(01)03057-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAntczak, C | |
| 245 | 0 | 0 |
_aReanalysis of the involvement of gamma-glutamyl transpeptidase in the cell activation process. _h[electronic resource] |
| 260 |
_bFEBS letters _cNov 2001 |
||
| 300 |
_a226-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBoron Compounds _xpharmacology |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aGenistein _xpharmacology |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoxazoles _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages _xcytology |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTyrphostins _xpharmacology |
| 650 | 0 | 4 |
_agamma-Glutamyltransferase _xantagonists & inhibitors |
| 700 | 1 | _aKarp, D R | |
| 700 | 1 | _aLondon, R E | |
| 700 | 1 | _aBauvois, B | |
| 773 | 0 |
_tFEBS letters _gvol. 508 _gno. 2 _gp. 226-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(01)03057-5 _zAvailable from publisher's website |
| 999 |
_c11633188 _d11633188 |
||